Lawlor Sally Bridget bought QNRX
December 1, 2025 · Form 4 insider transaction
Lawlor Sally Bridget bought 10,330 shares of Quoin Pharmaceuticals, Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,330
Price
$0.00
Total value
N/A
InsiderLawlor Sally Bridget
Role—
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 1, 2025
Filing dateDecember 3, 2025
Shares owned after10,330
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.; The option grant was approved by the Compensation Committee of the Board of Directors of the Issuer on December 1, 2025.; The option vests in four annual installments with 20% vesting on each of December 1, 2026, 2027 and 2028 and 40% vesting on December 1, 2029.